2125 - 2136 of 7601 results
0.25 CME CREDIT

Pain Points: Persistent Postoperative Pain

0.25 CME/MOC
0.25 AANP | 0.06 Pharmacology

Certain surgical procedures frequently lead to persistent postoperative pain. It is important to understand the risk factors and the pathophysiology that contribute to these chronic pain conditions and to understand approaches to prevent and manage these conditions. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).


0.3 CME CREDIT

The Advisory Committee on Immunization Practices (ACIP) makes shared clinical decision-making recommendations when individuals may benefit from vaccination, but broad vaccination of all people in that group is unlikely to have population-level impact. Such a recommendation is applicable to pneumococcal vaccines whereby pneumococcal conjugate vaccine (PCV13) is recommended for all adults 65 and older, while the administration of pneumococcal conjugate vaccine (PCV13) is based on shared decision-making. In this podcast, we will discuss the ACIP recommendations and the use of shared decision-making as it applies to pneumococcal vaccines. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/18/2020 and they are subject to change as new information is published.


1.5 CME CREDITS

Strategies for Effective Pain Management: The Basics

1.50 CME/MOC
1.50 AANP | 0.38 Pharmacology

This activity will discuss the epidemiology and pathophysiology of acute and chronic pain, patient assessment, assessment of risk for opioid-related aberrant behaviors, nonpharmacologic approaches to pain management, and non-opioid analgesics. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/19/2020 and they are subject to change as new information is published.


1.25 CME CREDITS

This activity will review the general principles of opioid prescribing, key concepts including misuse, abuse, tolerance, physical dependence, opioid use disorder, adverse effects and metabolism of opioids, and instructions for safe storage and disposal. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/19/2020 and they are subject to change as new information is published.


Strategies for Effective Pain Management

6.50 CME/MOC
6.83 AANP | 3.14 Pharmacology


FAQ for Updates from the 2018 ACC Scientific Sessions: Important Takeaways That Will Change Clinical Practice

This session will review a number of clinically relevant trials/topics recently presented at the American College of Cardiology Scientific Sessions in March 2018, including updates in the management of patients with hypercholesterolemia, heart failure, valvular heart disease, arrhythmias, and more.Guest: Ty J. Gluckman, MD, FACC, FAHA

This session will review a number of clinically relevant trials/topics recently presented at the American College of Cardiology Scientific Sessions in March 2018, including updates in the management of patients with hypercholesterolemia, heart failure, valvular heart disease, arrhythmias, and more.


0.25 CME CREDIT

The evidence of the impact of obesity and sedentary lifestyles on health and disease states is well established. Finding and applying strategies to assist people with the necessary behavior changes is a monumental task, but for Americans who are at lower income levels and in traditionally underserved populations, the evidence on what is effective is tragically lacking. The social determinants of health (SDOH) impact all aspects of care delivery, from access to care, to knowing what really works. Join us as we discuss a recent randomized controlled trial that evaluated a strategy that demonstrated weight loss in underserved populations, and may have promise to aid in this important aspect of care.


Heart Failure With Preserved Ejection Fraction: Common, Serious, and Treatable

Industry Podcast Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

Although heart failure with preserved ejection fraction (HFpEF) is common and increasing in prevalence, persistent misconceptions, including a perceived lack of therapeutic options, limit its effective management.1,2 In this episode, featuring cardiologist Dr. John Ryan of the University of Utah, we will counteract these misconceptions through exploration of various HFpEF patient profiles, covering key aspects of HFpEF diagnosis and optimal management in inpatient and outpatient settings.


Join us as we examine the risk of hospitalization for heart failure (HF) among patients with type 2 diabetes (T2D) and explore evidence-based risk reduction strategies that you can incorporate into your practice. We will discuss the results of the DECLARE trial, the largest cardiovascular (CV) outcomes trial to study hospitalization for HF reduction in patients with T2D and established CV disease or multiple CV risk factors. We'll also discuss the results of the landmark DAPA-HF trial that support FARXIGA being the FIRST and ONLY FDA-approved sodium-glucose cotransporter 2 inhibitor (SGLT2) for patients with HF with reduced ejection fraction (HFrEF) with and without T2D.


0.25 CME CREDIT

GLP-1 Receptor Agonists: Overcoming Barriers (Podcast)

0.25 CME/MOC
0.25 AANP | 0.25 Pharmacology

With the growing role of GLP-1 RAs in the management of diabetes, primary care providers are likely to find themselves discussing this class of medications with their patients. In this podcast, Dr. Michelle Magee will focus on barriers that patients may face to starting a GLP-1 RA and common questions that emerge in patient teaching. Faculty will review ways to troubleshoot these challenges and empower the clinician to engage in effective dialogue around this drug class. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/18/2020 and they are subject to change as new information is published.


0.35 CME CREDIT

In this podcast, Dr. Richard Pratley will answer Pri-Med learner questions submitted during recent CME sessions focusing on glucagon like peptide-1 receptor agonists (GLP-1 RAs). Join us for expert answers to questions about who can benefit from GLP-1 RAs, the safety of these medications in different populations, and much more. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/10/2020 and they are subject to change as new information is published.